Abstract Semaglutide, a GLP-1 receptor agonist, improves metabolic health and reduces liver fat in people with HIV (PWH) and metabolic dysfunction-associated steatotic liver disease (MASLD)
Comparison of Insulin Glargine U-300 and Insulin Degludec U-100 Efficacy Using TIR as the Primary Endpoint and Glycemic Variability and the Main Secondary End Point The efficacy of insulin glargine U-300 was compared to that of insulin degludec U-100 in InRange, a 12-week, randomized, active-controlled, open-label, head-to-head comparison trial
I've experienced a noticeable reduction in muscle and joint pain, which has improved my daily comfort
Lifestyle guidance to support the medications effects, not replace them
In 2019, Winfrey revealed she was diagnosed with pre-diabetes before doing WW